Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA

BACKGROUND: Real-world evidence for how US Crohn’s disease (CD) patients use ustekinumab is limited. OBJECTIVES: The aim of this study was to describe the persistence, maintenance dosing, and pre-post corticosteroid and opioid use for CD patients in the USA treated with ustekinumab and those treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhijie, Obando, Camilo, Muser, Erik, Kozma, Chris, Slaton, Terra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605940/
https://www.ncbi.nlm.nih.gov/pubmed/34136998
http://dx.doi.org/10.1007/s40801-021-00264-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605940/
https://www.ncbi.nlm.nih.gov/pubmed/34136998
http://dx.doi.org/10.1007/s40801-021-00264-5

Ejemplares similares